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Background: Prediabetes is a high-risk state for diabetes development, but little is known about the factors associated
with this state. The aim of the study was to identify modifiable risk factors associated with the presence of prediabetes
in men and women.
Methods: Cohort Study in Primary Health Care on the Evolution of Patients with Prediabetes (PREDAPS-Study) is a
prospective study on a cohort of 1184 subjects with prediabetes and another cohort of 838 subjects without glucose
metabolism disorders. It is being conducted by 125 general practitioners in Spain. Data for this analysis were collected
during the baseline stage in 2012. The modifiable risk factors included were: smoking habit, alcohol consumption, low
physical activity, inadequate diet, hypertension, dyslipidemia, and obesity. To assess independent association between
each factor and prediabetes, odds ratios (ORs) were estimated using logistic regression models.
Results: Abdominal obesity, low plasma levels of high-density lipoprotein cholesterol (HDL-cholesterol), and
hypertension were independently associated with the presence of prediabetes in both men and women. After
adjusting for all factors, the respective ORs (95% Confidence Intervals) were 1.98 (1.41-2.79), 1.88 (1.23-2.88)
and 1.86 (1.39-2.51) for men, and 1.89 (1.36-2.62), 1.58 (1.12-2.23) and 1.44 (1.07-1.92) for women. Also, general
obesity was a risk factor in both sexes but did not reach statistical significance among men, after adjusting
for all factors. Risky alcohol consumption was a risk factor for prediabetes in men, OR 1.49 (1.00-2.24).
Conclusions: Obesity, low HDL-cholesterol levels, and hypertension were modifiable risk factors independently
related to the presence of prediabetes in both sexes. The magnitudes of the associations were stronger for men than
women. Abdominal obesity in both men and women displayed the strongest association with prediabetes. The
findings suggest that there are some differences between men and women, which should be taken into account
when implementing specific recommendations to prevent or delay the onset of diabetes in adult population.
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Type 2 diabetes mellitus is a major public health prob-
lem, in Europe is estimated that 56.3 million −8.5%- of
adult population has diabetes and the prevalence is rais-
ing globally [1,2]. Additionally, there are some reasons
that exacerbate the problem: the impact of diabetes on
morbidity and mortality is well known [1,3,4]; the diag-
nosis is usually delayed around four to seven years after
disease onset largely due to absence of symptoms during
the early years of type 2 diabetes [5]; and, 10-20% of per-
sons with type 2 diabetes are found to have developed
cardiovascular complications by the date of diagnosis, as
a result of the high cardiovascular-disease risk entailed
by type 2 diabetes per se and the elevated prevalence of
cardiovascular risk factors among these patients [6]. In-
deed, this is why the promotion of healthy lifestyles and
an early diagnosis constitutes a key strategic line of ap-
proach to this health problem.
An appreciable percentage of the population has been
observed in the so-called "prediabetic" states. In Spain, the
prevalence estimated is above 12% [7]. A subject with pre-
diabetes is defined as any person having blood glucose
concentrations that are higher than normal but not of a
magnitude which would correspond to a diagnosis of type
2 diabetes [8]. Individuals with prediabetes have an in-
crease high risk of developing type 2 diabetes and associ-
ated complications, and most type 2 diabetes patients
have likely been in a state of hyperglycemia for several
years prior to diagnosis [9]. Prediabetes is also associated
with a higher risk of major cardiovascular diseases appear-
ing [10]. On the other hand, there evidence that changes
in lifestyle can reduce or delay the appearance of diabetes
in prediabetic individuals [11]. Hence, it is important to
identify individuals with a higher probability of presenting
some glucose metabolism disorder and know the related
risk factors.
Some authors assign the same risk factors that have
been identified in studies based on type 2 diabetes pa-
tients to subjects with prediabetic states [12,13]. Also, it
has been suggested that some lifestyle-related risk fac-
tors and other component factors of the metabolic syn-
drome, implicated in the progression of the prediabetic
stage to type 2 diabetes, might also contribute to the ap-
pearance of prediabetes [13,14]. However, few studies
about this issue have been based on prediabetic individ-
uals, and most of these have focused only on metabolic
factors [15,16]. Moreover, in the studies that have been
undertaken, the authors have tended to analyze the inde-
pendent effect of these factors, adjusting for sex, thereby
rendering it impossible to ascertain whether the factors
analyzed display a similar relationship with prediabetes
in both sexes. This is why this study aims to identify the
modifiable risk factors associated with prediabetes in
both men and women.Methods
Study design and subjects
The participants were the 2022 subjects included in the
Cohort Study in Primary Health Care on the Evolution
of Patients with Prediabetes (Evolución de pacientes con
prediabetes en Atención Primaria de Salud - PREDAPS).
The background and methodology of this study have
been previously published [17]; basically, it consisted of
a follow-up study of a cohort of 1184 subjects with pre-
diabetes and another cohort of 838 subjects without glu-
cose metabolism disorders. Baseline data were collected
in 2012, in the context of routine clinical practice, by
125 general practitioners distributed across Spain.
Patients who consecutively sought medical attention for
any reason and met the inclusion criteria were invited by
the researchers to participate in the study. A prediabetic
subject was defined as anyone who fulfilled the following
criteria: fasting plasma glucose (FPG) levels between 100
and 125 mg/dl, and/or a glycated hemoglobin HbA1c
range from 5.7% (39 mmol/mol) to 6.4% (46 mmol/mol)
in the preceding 6 months [8]. Patients who had no results
for the previous 6 months underwent analysis to deter-
mine these values. The selection of a prediabetic patient
was matched by the inclusion of another patient of the
same sex and similar age (+/− 5 years), in order to form
the cohort of subjects without glucose metabolism disor-
ders. The exclusion criteria for both cohorts of subjects
were age under 30 or over 74 years, and presence of any
of the following processes: diabetes, terminal disease,
pregnancy, major surgery or hospital admission in the pre-
ceding three months, or any hematologic diseases that
might interfere with the HbA1c value.
The study was classified by the Spanish Agency of Medicines
and Medical Devices (Agencia Española de Medicamentos y
Productos Sanitarios) as a Non-Interventional (Observational)
Post-Authorization Study, and the protocol was approved
by the Parc de Salut Mar Clinical Research Ethics
Committee in Barcelona. All the patients included in the
study signed the informed consent form required for their
participation.
Measures
Data on modifiable lifestyle-related risk factors were col-
lected. With respect to smoking habit, subjects were
classified into individuals who had smoked at some time
in their lives, individuals who currently smoke, and those
who had never smoked (ever smoker, current smoker
and never smoker). Based on alcohol consumption pat-
terns [18], subjects were classified into risky drinker, low-
risk drinker and abstinent categories. Men were considered
as risky drinker if they have more than 4 drinks on any sin-
gle day and/or they have more than 14 drinks per week.
Women were considered as risky drinker if they have more
than 3 drinks on any single day and/or they have more
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ceed both above limits -any single day and per week- were
classified as low-risk drinker. Subjects who do not drink
any alcohol were classified as abstinent. Data were ob-
tained on the frequency –number of times in the last two
weeks- and amount –mean time in minutes for each
session- of different types of physical activity, and, on the
basis of the data collected, the minutes per week of phys-
ical activity performed by each participant were estimated.
Subjects were classified into two categories according to if
they had followed or not the World Health Organization
(WHO) physical activity recommendations -accumulate
at least 150 minutes per week of moderate aerobic
activity or 75 minutes per week of vigorous aerobic activ-
ity, or an equivalent combination of moderate and vigor-
ous activity- [19].
Participants were asked to describe their usual break-
fast, with a wide variety of foods being included as pos-
sible replies. Subjects were allocated to two groups, those
who had no or an incomplete breakfast (e.g., only coffee,
milk, chocolate, cocoa or yogurt), and the rest. Based on
the data collected on the frequency of consumption of
fruit and vegetables, subjects were classified into the fol-
lowing two categories: those who ate these foods daily,
and those who ate them less often. In the case of con-
sumption of fish and legumes, subjects were classified into
those who ate these foods three or more times per week,
and those who ate them less frequently [20].
Data on blood pressure, height, weight, and waist cir-
cumference were obtained by physical examination. Pa-
tients were deemed to be hypertensive if their mean
systolic pressure -three readings- was ≥140 mmHg, or
their mean diastolic pressure was ≥90 mmHg, or if they
were undergoing treatment with some type of antihyper-
tensive medication, or if they had personal history of
hypertension. General obesity was defined as a Body
Mass Index (BMI) ≥30 Kg/m2, and abdominal obesity as
a waist circumference ≥102 cm in men and ≥88 cm in
women [21].
Finally, plasma lipid concentrations were determined,
subjects were deemed to have high cholesterol if their
levels were ≥250 mg/dl, and high triglycerides if their
levels were ≥200 mg/dl; and they were deemed to have
low high-density lipoprotein cholesterol (HDL-cholesterol)
if their plasma levels were <40 mg/dl in men and <50 mg/
dl in women. Other variables, included in this study
due to their potential confounding effect with respect
to the association studied, were: age, marital status,
educational level, region of residence, and family his-
tory of diabetes.
Statistical analyses
We estimated the percentage of patients who presented
each of these risk factors in the cohort of subjects withprediabetes and in the cohort without glucose metabolism
disorders, with a breakdown by sex. We assessed the statis-
tical significance of the difference in percentages between
the two groups using the chi-squared test. A p-value <0.05
were considered statistically significant. In order to evalu-
ate the independent association, in men and in women, be-
tween risk factors and presence of prediabetes, logistic
regression models were performed. First, we estimated the
association between each risk factor and prediabetes using
models adjusted for age, marital status, educational level,
region of residence, and family history of diabetes. Second,
all risk factors were introduced in the models. The esti-
mates were expressed in odds ratios (ORs) and 95% confi-
dence intervals (95% CIs). These analyses were performed
using the SPSS statistical package version 19.
Results
Characteristics of subjects with prediabetes and those with-
out glucose metabolism disorders are shown in Table 1,
with a breakdown by sex. Whereas age, percentage of low
educational level, and presence of family history of dia-
betes were higher among subjects with prediabetes, in
both men and women, no statistically significant differ-
ences were found in terms of marital status or region of
residence.
The frequency of risk factors in both cohorts of subjects
is shown in Table 2. No significant differences in physical
activity, diet, and hypercholesterolemia were found. Men
and women with prediabetes registered a higher frequency
of hypertension, low HDL-Cholesterol level, general obes-
ity, and abdominal obesity than men and women without
glucose metabolism disorders. Among men, the percent-
age of current smokers was lower and the percentage of
risky drinkers was higher in the prediabetes group than in
the group without glucose metabolism disorders. Women
with prediabetes displayed a higher prevalence of hypertri-
glyceridemia than women without glucose metabolism
disorders.
The ORs that reflect the association between each of
the risk factors and presence of prediabetes in men and
in women are shown in Tables 3 and 4, respectively. In
model 1, the ORs -adjusted for age, educational level,
marital status, region of residence, and family history of
diabetes- showed an elevated magnitude for hypertension,
low HDL-Cholesterol, general obesity, and abdominal
obesity in men and women alike. In men, risky alco-
hol consumption and hypertrigliceridemia also yielded
elevated and significant ORs. In women, incomplete
or absent breakfast and hypertrigliceridemia were ele-
vated but no significant OR.
After adjustment for all risk factors (model 2), hyperten-
sion, low HDL-Cholesterol plasma levels and abdominal
obesity showed an independent association with prediabe-
tes in men and women. Furthermore, alcohol consumption
Table 1 Percent distribution of sociodemographic characteristics and family history of diabetes mellitus in men and
women
Characteristics Men Women
With prediabetes Without glucose
metabolism disorders
p-value With prediabetes Without glucose
metabolism disorders
p-value
N = 595 N = 388 N = 589 N = 450
Age
30-49 years 16.5 22.4 0.013 15.1 25.3 <0.001
50-64 years 50.4 51.8 49.1 46.4
65-74 years 33.1 25.8 35.8 28.2
Educational level*
Low 59.0 52.3 0.042 70.1 59.6 <0.001
High 41.0 47.7 29.9 40.4
Marital status
Without partner 15.8 18.3 0.337 27.5 27.1 0.944
Married or with partner 84.2 81.7 72.5 72.9
Region of residence†
North 41.5 39.4 0.131 36.2 36.0 0.955
Centre 30.4 36.3 33.6 34.4
South 28.1 24.2 30.2 29.6
Family history of diabetes‡
Yes 43.4 33.8 0.003 50.6 34.2 <0.001
No 56.6 66.2 49.4 65.8
Data are showed in percentages.
*Low educational level: lower than secondary (equivalent to less than 12 years of education); high educational level: secondary or higher (equivalent to 12 years
or more of education).
†North: Galicia, Asturias, Cantabria, Basque Country, Navarre, La Rioja, Aragon, Catalonia; Centre: Castile- León, Madrid, Extremadura, Castile-La Mancha; South:
Andalusia, Murcia, Valencia, Balearic Isles, Canary Islands.
‡Family history of diabetes in father, mother, siblings or children.
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obesity showed an independent association in women.
Discussion
This study showed that known cardiovascular risk factors,
specifically abdominal obesity, hypertension and low
HDL-Cholesterol levels, are independently associated with
the presence of prediabetes in women and men alike.
Additionally, general obesity in women and alcohol con-
sumption in men are risk factors for prediabetes. General
obesity was also associated with prediabetes in men, al-
though the statistical significance disappeared after adjust-
ment for all factors. The modifiable risk factors that
showed the strongest association with prediabetes was ab-
dominal obesity. The magnitudes of the associations were
stronger for men than women. Smoking, physical activity,
and diet habits not showed significant relationship with
prediabetes.
As other studies, obesity in our study subjects –both
general and, more specifically, abdominal– was associ-
ated with the presence of prediabetes [7,22]. Moreover,
when a wide number of risk factors had been examined
simultaneously, as we have done in our study, waistcircumference had showed the strongest direct effect on
prediabetes [22]. Although the mechanisms are not clear,
excess adipose tissue has been reported to release fatty
acids, something that induces resistance to insulin in the
muscle and, in turn, leads to elevation of plasma glucose
levels [13]. Also, measures of abdominal obesity have
been found as the strongest predictors of diabetes [23].
The association between hypertension/dyslipidemia and
prediabetes has been reported previously [7,14,24]. In our
study, hypertension displayed an important association
with prediabetes, particularly among men. Hypertriglyc-
eridemia and low HDL-Cholesterol levels were also seen
to be associated with prediabetes, though only the associ-
ation with low HDL-Cholesterol levels proved to be signifi-
cant in both sexes. Moreover, when the rest variables had
been adjusted for, the magnitude of the association be-
tween these factors and prediabetes fell substantially in
both sexes, though hypertension and low HDL-Cholesterol
levels remain as independent risk factors for prediabetes.
This weakening, in the association between dyslipidemia
and hypertension with prediabetes, is basically due to the
inclusion of obesity in the model. This is supported by the
strong association existing between obesity and blood
Table 2 Percent distribution of modifiable risk factors present in men and women










N = 595 N = 388 N = 589 N = 450
Smoking habit
Current smoker 18.7 24.7 0.003 14.6 20.2 0.580
Alcohol consumption
Risky drinker 34.1 31.2 0.015 12.7 12.9 0.469
Physical activity
WHO recommendations not followed 38.4 37.4 0.788 51.2 49.6 0.617
Diet
Incomplete or absent breakfast 16.3 15.7 0.859 10.9 8.0 0.137
Non-daily fruit consumption 26.6 25.8 0.824 17.7 20.0 0.377
Non-daily vegetable consumption 49.6 52.1 0.473 36.7 37.1 0.897
Fish consumed <3 times per week 57.6 61.1 0.289 52.8 54.9 0.530
Legumes consumed <3 times per week 64.4 68.0 0.243 69.1 70.2 0.734
Blood pressure
Hypertension* 72.3 51.3 <0.001 61.6 44.2 <0.001
Lipids
Hypercholesterolemia† 11.3 12.9 0.481 16.6 14.7 0.440
Hypertriglyceridemia‡ 14.6 10.4 0.064 10.9 6.2 0.011
Low HDL-Cholesterol§ 20.4 12.2 0.001 28.3 18.9 0.001
Obesity
General obesity|| 42.4 23.2 <0.001 43.6 25.1 <0.001
Abdominal obesity¶ 59.4 33.0 <0.001 75.2 52.2 <0.001
Data are showed in percentages.
*Hypertension: mean systolic pressure ≥140 mmHg, or mean diastolic pressure ≥90 mmHg, or being under treatment with antihypertensive drugs, or a personal
history of arterial hypertension.
†Hypercholesterolemia: plasma total cholesterol ≥250 mg/dl.
‡Hypertriglyceridemia: plasma triglycerides ≥200 mg/dl.
§Low HDL-Cholesterol: plasma High-Density Lipoprotein cholesterol <40 mg/dl in men, and <50 mg/dl in women.
||General obesity: Body Mass Index ≥30 kg/m2.
¶Abdominal obesity: waist circumference ≥102 cm in men, and ≥88 cm in women.
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[25]. Also, Bardenheier et al. found in their model that
the direct effect of hypertension on prediabetes was con-
founded by waist circumference [22].
A number of studies have reported that alcohol con-
sumption in men, and excessive consumption in particu-
lar, is associated with the appearance of prediabetes and
type 2 diabetes, whereas alcohol consumption in women
displays a protective effect for the appearance of these
health problems [26,27]. In our study, alcohol consump-
tion was found as a modifiable risk factor for prediabetes
in men. Likewise, a lower frequency of risky drinkers was
observed among women with prediabetes than among
those without glucose disorders, but the differences were
not significant.
It has noted that frequency and quality of breakfast is
related with regulation of appetite and control of plasmaglucose levels [28]. Also, positive associations between
skipping breakfast and fasting glucose and fasting insulin
have been observed [29]. In our study, although the mag-
nitude of this association was high in women, no statisti-
cally significant relationship was found between absent or
incomplete breakfast and prediabetes. On the other hand,
no relationship was found between consumption of other
foods and the presence of prediabetes. This is consistent
with the observed by others in relation to fruit and vegeta-
bles consumption [14], but it is contrary to the protective
effect of foods such as fish, vegetables and legumes on glu-
cose disorders that has been reported [30].
Although the physical exercise is known as a protective
factor for the development of type 2 diabetes [31], the fail-
ure to follow the WHO physical-activity recommenda-
tions was not shown to be associated with the presence of
prediabetes in our study. Other studies have obtained
Table 3 Association between modifiable risk factors and presence of prediabetes in men
Risk factors Model 1 Model 2
OR (95% CI) OR (95% CI)
Smoking habit
Current smoker vs. never smoker 0.94 (0.65–1.37) 0.77 (0.51–1.16)
Consumption of alcohol
Risky drinker vs. abstinent 1.58 (1.09–2.28) 1.49 (1.00–2.24)
Physical activity
WHO recommendations not followed vs. followed 1.13 (0.86–1.48) 1.10 (0.82–1.49)
Breakfast
Incomplete or absent vs. complete 1.12 (0.78–1.60) 1.10 (0.75–1.63)
Consumption of fruit
Non-daily vs. daily consumption 1.16 (0.86–1.57) 1.26 (0.89–1.77)
Consumption of vegetables
Non-daily vs. daily consumption 0.96 (0.74–1.25) 0.88 (0.65–1.19)
Consumption of fish
Consumption of <3 vs. >3 times per week 0.88 (0.67–1.16) 0.91 (0.68–1.23)
Consumption of legumes
Consumption of <3 vs. >3 times per week 0.87 (0.66–1.14) 0.84 (0.63–1.13)
Blood pressure
Hypertension* vs. no hypertension 2.33 (1.76–3.08) 1.86 (1.39–2.51)
Lipids
Hypercholesterolemia† vs. no hypercholesterolemia 0.85 (0.57–1.27) 0.99 (0.64–1.53)
Hypertriglyceridemia‡ vs. no hypertriglyceridemia 1.61 (1.07–2.42) 1.19 (0.75–1.90)
Low HDL-Cholesterol§ vs. high HDL-Cholesterol 1.94 (1.34–2.82) 1.88 (1.23–2.88)
Obesity
General obesity|| vs. no general obesity 2.51 (1.88–3.36) 1.43 (0.99–2.06)
Abdominal obesity¶ vs. no abdominal obesity 2.87 (2.19–3.77) 1.98 (1.41–2.79)
Data are showed in odds ratios (OR) and 95% confidence intervals (95% CI). Model 1 is adjusted for age, educational level, marital status, region of residence, and
family history of diabetes. Model 2 is adjusted for all the variables in the table plus age, educational level, marital status, region of residence, and family history of
diabetes. Data in bold indicate statistically significant associations.
*Hypertension: mean systolic pressure ≥140 mmHg, or mean diastolic pressure ≥90 mmHg, or being under treatment with antihypertensive drugs, or a personal
history of arterial hypertension.
†Hypercholesterolemia: plasma total cholesterol ≥250 mg/dl.
‡Hypertriglyceridemia: plasma triglycerides ≥200 mg/dl.
§Low HDL-Cholesterol: plasma High-Density Lipoprotein cholesterol <40 mg/dl.
||General obesity: Body Mass Index ≥30 kg/m2.
¶Abdominal obesity: waist circumference ≥102 cm.
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risk factor of diabetes [32]; however, there is inconsistent
evidence about prediabetes. Some findings are agreed with
ours [14], but in others smoking was reported as a risk
factor [33]. The criteria of prediabetes used in above stud-
ies differ from those we used in our study, and therefore,
the groups formed in each study are not fully comparable
to each other.
Strengths and limitations
The main strength of the present study is the focus on the
prediabetes state. Also, we have included a large numberof participants from across Spain from primary care set-
ting. However, when it comes to interpreting the findings,
some limitations must be borne in mind. First, this study
should be consider as a cross-sectional in design, since it
was based on data collected during the baseline stage of a
follow-up study. Hence, one cannot exclude the possi-
bility that subjects with prediabetes might have modi-
fied their lifestyles and acquired healthier habits. Second,
this study included subjects with prediabetes based on
HbA1c and FPG criteria, the exclusion of oral glucose
overload as criteria for prediabetes was due to it is an ex-
pensive and impractical procedure at a primary health-
Table 4 Association between modifiable risk factors and presence of prediabetes in women
Risk factors Model 1 Model 2
OR (95% CI) OR (95% CI)
Smoking habit
Current smoker vs. never smoker 0.82 (0.57–1.17) 0.75 (0.50–1.11)
Consumption of alcohol
Risky drinker vs. abstinent 1.00 (0.66–1.50) 1.13 (0.72–1.76)
Physical activity
WHO recommendations not followed vs. followed 1.15 (0.89–1.48) 1.04 (0.79–1.37)
Breakfast
Incomplete or absent vs. complete 1.48 (0.95–2.30) 1.43 (0.89–2.30)
Consumption of fruit
Non-daily vs. daily consumption 1.06 (0.76–1.48) 0.94 (0.65–1.37)
Consumption of vegetables
Non-daily vs. daily consumption 0.98 (0.75–1.27) 0.93 (0.70–1.24)
Consumption of fish
Consumption of <3 vs. >3 times per week 0.95 (0.73–1.23) 0.94 (0.71–1.26)
Consumption of legumes
Consumption of <3 vs. >3 times per week 0.94 (0.71–1.23) 0.88 (0.66–1.19)
Blood pressure
Hypertension* vs. no hypertension 1.79 (1.37–2.35) 1.44 (1.07–1.92)
Lipids
Hypercholesterolemia† vs. no hypercholesterolemia 1.04 (0.74–1.48) 1.13 (0.78–1.65)
Hypertriglyceridemia‡ vs. no hypertriglyceridemia 1.58 (0.98–2.54) 1.08 (0.64–1.80)
Low HDL-Cholesterol§ vs. high HDL-Cholesterol 1.82 (1.33–2.49) 1.58 (1.12–2.23)
Obesity
General obesity|| vs. no general obesity 2.26 (1.71–2.99) 1.42 (1.01–1.98)
Abdominal obesity¶ vs. no abdominal obesity 2.55 (1.94–3.35) 1.89 (1.36–2.62)
Data are showed in odds ratios (OR) and 95% confidence intervals (95% CI). Model 1 is adjusted for age, educational level, marital status, region of residence, and
family history of diabetes. Model 2 is adjusted for all the variables in the table plus age, educational level, marital status, region of residence, and family history of
diabetes. Data in bold indicate statistically significant associations.
*Hypertension: mean systolic pressure ≥140 mmHg, or mean diastolic pressure ≥90 mmHg, or being under treatment with antihypertensive drugs, or a personal
history of arterial hypertension.
†Hypercholesterolemia: plasma total cholesterol ≥250 mg/dl.
‡Hypertriglyceridemia: plasma triglycerides ≥200 mg/dl.
§Low HDL-Cholesterol: plasma High-Density Lipoprotein cholesterol <50 mg/dl.
||General obesity: Body Mass Index ≥30 kg/m2.
¶Abdominal obesity: waist circumference ≥ 88 cm.
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been widely accepted by the American Diabetes Associ-
ation [8]. Third, the number of patients included in the
prediabetes cohort is greater than the number of patients
included in the cohort of subjects without glucose metab-
olism disorders. Many physicians included patients with
normal FPG levels in the second cohort without waiting
for the result of the HbA1c analytical tests, when the
HbA1c results arrived, some patients were found to be
prediabetic and were changed to the prediabetes cohort.
Fourth, in our study subjects were health service users,
this mean that it would be expected that subjects without
glucose metabolism disorders display a higher frequencyof risk factors than would the general population;
thus, the possibility of identifying risk factors associated
with prediabetes would be correspondingly lower than in
population-based studies.
Conclusions
This study provides useful information when considering
early detection of individuals with high risk of develop-
ment diabetes and cardiovascular diseases. The detection
of prediabetes in an individual should be accompan-
ied by interventions addressing modifiable risk factors.
Obesity, hypertension and low HDL-cholesterol levels
have been the modifiable risk factors independently
Díaz-Redondo et al. BMC Family Practice  (2015) 16:5 Page 8 of 9related to the presence of prediabetes identified in this
study; also, alcohol consumption in men. The magnitudes
of the associations were stronger for men than women.
Abdominal obesity in both men and women displayed the
strongest association with prediabetes.
The available evidence is still scarce, further studies are
needed to check these findings and to confirm possible ex-
planations. The existence of differences between men and
women underscore the need to analyze data separately by
sex, in order to implement specific recommendations to
primary prevention of diabetes and cardiovascular diseases
in adult population. Finally, these results might influence
the primary care practice where, for example, in men, the
alcohol consumption should be considered as an add-
itional risk factor of prediabetes compared to women.
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